XOMA Co. (NASDAQ:XOMAO – Get Free Report) was the target of a large decline in short interest in December. As of December 31st, there was short interest totalling 2,500 shares, a decline of 34.2% from the December 15th total of 3,800 shares. Based on an average daily trading volume, of 3,000 shares, the short-interest ratio is presently 0.8 days.
XOMA Price Performance
Shares of XOMAO stock opened at $25.08 on Tuesday. The company’s fifty day simple moving average is $25.46 and its two-hundred day simple moving average is $25.40. XOMA has a 1 year low of $23.99 and a 1 year high of $25.87.
XOMA Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Friday, January 3rd will be issued a dividend of $0.5234 per share. This represents a $2.09 dividend on an annualized basis and a yield of 8.35%. The ex-dividend date of this dividend is Friday, January 3rd.
About XOMA
XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.
Recommended Stories
- Five stocks we like better than XOMA
- What is the FTSE 100 index?
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- Top Biotech Stocks: Exploring Innovation Opportunities
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.